Palantir, MicroStrategy Could Be Added to Nasdaq 100. Moderna, Super Micro Could Be Dropped

Barron's36minutes ago

Weekly Buzz: Tech stocks hit high scores on ominous day

Kevin Travers20minutes ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing

MT Newswires30minutes ago

Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.

Barrons11:46 ET

Vir Gets FDA Breakthrough Therapy Status for Two Drugs

Seeking AlphaDec 12 17:03 ET

Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 11 12:41 ET